TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
BRKR

Bruker Corporation

Healthcare · Medical Devices

61.60$ +0.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Bruker Corporation (BRKR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 134 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow BRKR
Line item 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5.4 -0.2 -11 -11 -6.1 -0.9 42 38 28 107 150 156 88 133 145 114 229 131 154 240 213 333 282 262 350 251 134
3.5 4.1 6.0 8.2 17 9.8 8.6 13 13 30 30 36 3.0 59 61 60 53 54 64 65 76 80 89 88 115 184 220
0.2 0.0 -0.1 0.0 0.0 1.5 2.2 4.5 6.3 6.9 7.9 7.8 6.6 9.4 8.0 9.4 11 11 9.6 16 17 28 24 25 20
2.6 1.5 8.9 4.9 42 54 48 34 -21 -13 39 -3.8 4.2 -6.5 41 13
-0.4 -4.4 -21 -22 -11 -6.5 32 8.6 -18 10 37 -6.4 -102 -58 -53 -39 46 -85 -41 -42 -75 76 -125 -144 -88 -78 -145
4.2 5.6 18 16 5.5 7.3 3.2 7.6 16 47 16 32 54 73 50 34 34 37 44 49 73 98 92 119 107 115 120
-4.4 -86 -7.4 30 -10 -1.5 -10 12 -21 -48 -18 -299 -69 -93 -60 -202 -102 -22 -30 -123 -158 -193 -192 -252 -326 -1,757 -197
0.3 23 0.1 0.4 0.6 0.6 1.1 42 26 25 25 25 25 24 30 29 30 23
-3.1 0.0 3.7 185 3.3 3.9 -0.2 -0.3 -90 -160 -152 -152 -142 -123 -153 -263 -152 0.0 -10
0.2 31 19 -0.1 -88 147 3.1 -94 463 -8.4 490 0.3 -22 876 -491
0.4 105 6.4 3.5 -8.1 6.8 -7.2 -64 9.1 -235 -84 168 3.3 34 27 6.7 -168 -27 -159 -112 300 -162 319 -415 -193 1,230 135
1.3 19 -13 24 -22 7.2 21 -10 21 -166 41 23 16 65 128 -119 -52 75 -17 -2.6 356 3.6 386 -423 -157 -305 116
1.2 -5.8 -29 -27 -12 -8.2 39 30 12 60 134 124 33 60 95 81 195 94 111 191 140 235 190 143 243 136 14

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?